Ponce, Kyrie Jay .

HRN: 26-46-17  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/31/2024
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
12/31/2024
01/07/2025
INTRAVENOUS
110 Mg
Every 24 Hours
PCAP-C
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: